Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 56 entries
Sorted by: Best Match Show Resources per page
Commentary: Resilience Defined: An Alternative Perspective.

Journal of pediatric psychology

Rosenberg AR, Yi-Frazier JP.
PMID: 27013701
J Pediatr Psychol. 2016 Jun;41(5):506-9. doi: 10.1093/jpepsy/jsw018. Epub 2016 Mar 24.

No abstract available.

Cite
Rosenberg AR, Yi-Frazier JP. Commentary: Resilience Defined: An Alternative Perspective. J Pediatr Psychol. 2016;41(5):506-9doi: 10.1093/jpepsy/jsw018.
Rosenberg, A. R., & Yi-Frazier, J. P. (2016). Commentary: Resilience Defined: An Alternative Perspective. Journal of pediatric psychology, 41(5), 506-9. https://doi.org/10.1093/jpepsy/jsw018
Rosenberg, Abby R, and Yi-Frazier, Joyce P. "Commentary: Resilience Defined: An Alternative Perspective." Journal of pediatric psychology vol. 41,5 (2016): 506-9. doi: https://doi.org/10.1093/jpepsy/jsw018
Rosenberg AR, Yi-Frazier JP. Commentary: Resilience Defined: An Alternative Perspective. J Pediatr Psychol. 2016 Jun;41(5):506-9. doi: 10.1093/jpepsy/jsw018. Epub 2016 Mar 24. PMID: 27013701; PMCID: PMC4888119.
Copy Download .nbib Format: NLM
Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission.

Journal of the Pediatric Infectious Diseases Society

Gantt S, Payant R, Carlsson J, Micek MA, Blanco AJ, Beck IA, Matunha L, Montoya P, Matediana E, Gloyd S, Frenkel LM.
PMID: 23687579
J Pediatric Infect Dis Soc. 2012 Sep;1(3):244-9. doi: 10.1093/jpids/pis065. Epub 2012 Jul 03.

Among 30 human immunodeficiency virus type 1 (HIV-1)-infected women who received single-dose nevirapine (NVP), 17 (57%) had NVP-resistant HIV-1 detected in breast milk. NVP resistance in breast milk persisted for at least 8 months postpartum and was apparently transmitted...

Cite
Gantt S, Payant R, Carlsson J, et al. Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission. J Pediatric Infect Dis Soc. 2012;1(3):244-9doi: 10.1093/jpids/pis065.
Gantt, S., Payant, R., Carlsson, J., Micek, M. A., Blanco, A. J., Beck, I. A., Matunha, L., Montoya, P., Matediana, E., Gloyd, S., & Frenkel, L. M. (2012). Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission. Journal of the Pediatric Infectious Diseases Society, 1(3), 244-9. https://doi.org/10.1093/jpids/pis065
Gantt, Soren, et al. "Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission." Journal of the Pediatric Infectious Diseases Society vol. 1,3 (2012): 244-9. doi: https://doi.org/10.1093/jpids/pis065
Gantt S, Payant R, Carlsson J, Micek MA, Blanco AJ, Beck IA, Matunha L, Montoya P, Matediana E, Gloyd S, Frenkel LM. Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission. J Pediatric Infect Dis Soc. 2012 Sep;1(3):244-9. doi: 10.1093/jpids/pis065. Epub 2012 Jul 03. PMID: 23687579; PMCID: PMC3656540.
Copy Download .nbib Format: NLM
Comparison of two nasal cell collection methods in determining cyclic adenosine monophosphate levels and its association with olfaction: A feasibility study.

Allergy & rhinology (Providence, R.I.)

Liu JJ, Chan GC, Hecht AS, Storm DR, Davis GE.
PMID: 24613015
Allergy Rhinol (Providence). 2014 Mar;5(1):17-21. doi: 10.2500/ar.2014.5.0079. Epub 2014 Mar 07.

Cyclic adenosine monophosphate (cAMP) is a second messenger that may be associated with olfactory function. No known studies have compared existing collection methods for determining nasal cAMP levels. This is a prospective study comparing the comfort and reliability of...

Cite
Liu JJ, Chan GC, Hecht AS, et al. Comparison of two nasal cell collection methods in determining cyclic adenosine monophosphate levels and its association with olfaction: A feasibility study. Allergy Rhinol (Providence). 2014;5(1):17-21doi: 10.2500/ar.2014.5.0079.
Liu, J. J., Chan, G. C., Hecht, A. S., Storm, D. R., & Davis, G. E. (2014). Comparison of two nasal cell collection methods in determining cyclic adenosine monophosphate levels and its association with olfaction: A feasibility study. Allergy & rhinology (Providence, R.I.), 5(1), 17-21. https://doi.org/10.2500/ar.2014.5.0079
Liu, Jack J, et al. "Comparison of two nasal cell collection methods in determining cyclic adenosine monophosphate levels and its association with olfaction: A feasibility study." Allergy & rhinology (Providence, R.I.) vol. 5,1 (2014): 17-21. doi: https://doi.org/10.2500/ar.2014.5.0079
Liu JJ, Chan GC, Hecht AS, Storm DR, Davis GE. Comparison of two nasal cell collection methods in determining cyclic adenosine monophosphate levels and its association with olfaction: A feasibility study. Allergy Rhinol (Providence). 2014 Mar;5(1):17-21. doi: 10.2500/ar.2014.5.0079. Epub 2014 Mar 07. PMID: 24613015; PMCID: PMC4019739.
Copy Download .nbib Format: NLM
Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics.

The Journal of infectious diseases

Waghmare A, Krantz EM, Baral S, Vasquez E, Loeffelholz T, Chung EL, Pandey U, Kuypers J, Duke ER, Jerome KR, Greninger AL, Reeves DB, Hladik F, Cardozo-Ojeda EF, Boeckh M, Schiffer JT.
PMID: 32710762
J Infect Dis. 2020 Jul 25; doi: 10.1093/infdis/jiaa451. Epub 2020 Jul 25.

The SARS-CoV-2 pandemic demonstrates the need for accurate and convenient approaches to diagnose and therapeutically monitor respiratory viral infections. We demonstrated that self-sampling with foam swabs is well-tolerated and provides quantitative viral output concordant with flocked swabs. Using longitudinal...

Cite
Waghmare A, Krantz EM, Baral S, et al. Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics. J Infect Dis. 2020;doi: 10.1093/infdis/jiaa451.
Waghmare, A., Krantz, E. M., Baral, S., Vasquez, E., Loeffelholz, T., Chung, E. L., Pandey, U., Kuypers, J., Duke, E. R., Jerome, K. R., Greninger, A. L., Reeves, D. B., Hladik, F., Cardozo-Ojeda, E. F., Boeckh, M., & Schiffer, J. T. (2020). Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics. The Journal of infectious diseases, . https://doi.org/10.1093/infdis/jiaa451
Waghmare, Alpana, et al. "Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics." The Journal of infectious diseases vol. (2020). doi: https://doi.org/10.1093/infdis/jiaa451
Waghmare A, Krantz EM, Baral S, Vasquez E, Loeffelholz T, Chung EL, Pandey U, Kuypers J, Duke ER, Jerome KR, Greninger AL, Reeves DB, Hladik F, Cardozo-Ojeda EF, Boeckh M, Schiffer JT. Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics. J Infect Dis. 2020 Jul 25; doi: 10.1093/infdis/jiaa451. Epub 2020 Jul 25. PMID: 32710762; PMCID: PMC7454707.
Copy Download .nbib Format: NLM
Parental Enrollment Decision-Making for a Neonatal Clinical Trial.

The Journal of pediatrics

Weiss EM, Guttmann KF, Olszewski AE, Magnus BE, Li S, Kim SYH, Shah AR, Juul SE, Wu YW, Ahmad KA, Bendel-Stenzel E, Isaza NA, Lampland AL, Mathur AM, Rao R, Riley D, Russell DG, Salih ZNI, Torr CB, Weitkamp JH, Anani UE, Chang T, Dudley J, Flibotte J, Havrilla EM, O'Kane AC, Perez K, Stanley BJ, Shah SK, Wilfond BS.
PMID: 34400207
J Pediatr. 2021 Dec;239:143-149.e3. doi: 10.1016/j.jpeds.2021.08.014. Epub 2021 Aug 14.

OBJECTIVE: To describe the parental experience of recruitment and assess differences between parents who participated and those who declined to enroll in a neonatal clinical trial.STUDY DESIGN: This was a survey conducted at 12 US neonatal intensive care units...

Cite
Weiss EM, Guttmann KF, Olszewski AE, et al. Parental Enrollment Decision-Making for a Neonatal Clinical Trial. J Pediatr. 2021;239:143-149.e3doi: 10.1016/j.jpeds.2021.08.014.
Weiss, E. M., Guttmann, K. F., Olszewski, A. E., Magnus, B. E., Li, S., Kim, S. Y. H., Shah, A. R., Juul, S. E., Wu, Y. W., Ahmad, K. A., Bendel-Stenzel, E., Isaza, N. A., Lampland, A. L., Mathur, A. M., Rao, R., Riley, D., Russell, D. G., Salih, Z. N. I., Torr, C. B., Weitkamp, J. H., Anani, U. E., Chang, T., Dudley, J., Flibotte, J., Havrilla, E. M., O'Kane, A. C., Perez, K., Stanley, B. J., Shah, S. K., & Wilfond, B. S. (2021). Parental Enrollment Decision-Making for a Neonatal Clinical Trial. The Journal of pediatrics, 239143-149.e3. https://doi.org/10.1016/j.jpeds.2021.08.014
Weiss, Elliott Mark, et al. "Parental Enrollment Decision-Making for a Neonatal Clinical Trial." The Journal of pediatrics vol. 239 (2021): 143-149.e3. doi: https://doi.org/10.1016/j.jpeds.2021.08.014
Weiss EM, Guttmann KF, Olszewski AE, Magnus BE, Li S, Kim SYH, Shah AR, Juul SE, Wu YW, Ahmad KA, Bendel-Stenzel E, Isaza NA, Lampland AL, Mathur AM, Rao R, Riley D, Russell DG, Salih ZNI, Torr CB, Weitkamp JH, Anani UE, Chang T, Dudley J, Flibotte J, Havrilla EM, O'Kane AC, Perez K, Stanley BJ, Shah SK, Wilfond BS. Parental Enrollment Decision-Making for a Neonatal Clinical Trial. J Pediatr. 2021 Dec;239:143-149.e3. doi: 10.1016/j.jpeds.2021.08.014. Epub 2021 Aug 14. PMID: 34400207; PMCID: PMC8610170.
Copy Download .nbib Format: NLM
Microglial depletion abolishes ischemic preconditioning in white matter.

Glia

Hamner MA, McDonough A, Gong DC, Todd LJ, Rojas G, Hodecker S, Ransom CB, Reh TA, Ransom BR, Weinstein JR.
PMID: 34939240
Glia. 2021 Dec 23; doi: 10.1002/glia.24132. Epub 2021 Dec 23.

Ischemic preconditioning (IPC) is a phenomenon whereby a brief, non-injurious ischemic exposure enhances tolerance to a subsequent ischemic challenge. The mechanism of IPC has mainly been studied in rodent stroke models where gray matter (GM) constitutes about 85% of...

Cite
Hamner MA, McDonough A, Gong DC, et al. Microglial depletion abolishes ischemic preconditioning in white matter. Glia. 2021;doi: 10.1002/glia.24132.
Hamner, M. A., McDonough, A., Gong, D. C., Todd, L. J., Rojas, G., Hodecker, S., Ransom, C. B., Reh, T. A., Ransom, B. R., & Weinstein, J. R. (2021). Microglial depletion abolishes ischemic preconditioning in white matter. Glia, . https://doi.org/10.1002/glia.24132
Hamner, Margaret A, et al. "Microglial depletion abolishes ischemic preconditioning in white matter." Glia vol. (2021). doi: https://doi.org/10.1002/glia.24132
Hamner MA, McDonough A, Gong DC, Todd LJ, Rojas G, Hodecker S, Ransom CB, Reh TA, Ransom BR, Weinstein JR. Microglial depletion abolishes ischemic preconditioning in white matter. Glia. 2021 Dec 23; doi: 10.1002/glia.24132. Epub 2021 Dec 23. PMID: 34939240.
Copy Download .nbib Format: NLM
Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testing.

Health policy and technology

Haas CB, Scrol A, Jujjavarapu C, Jarvik GP, Henrikson NB.
PMID: 34040952
Health Policy Technol. 2021 Jun;10(2). doi: 10.1016/j.hlpt.2021.100511. Epub 2021 Apr 22.

OBJECTIVE: To assess the usefulness a mobile based application to send genetic test results to at-risk family members in a U.S. integrated health system.METHODS: We conducted semi-structured in-person interviews with members of Kaiser Permanente Washington who had enrolled in...

Cite
Haas CB, Scrol A, Jujjavarapu C, et al. Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testing. Health Policy Technol. 2021;10(2)doi: 10.1016/j.hlpt.2021.100511.
Haas, C. B., Scrol, A., Jujjavarapu, C., Jarvik, G. P., & Henrikson, N. B. (2021). Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testing. Health policy and technology, 10(2), . https://doi.org/10.1016/j.hlpt.2021.100511
Haas, Cameron B, et al. "Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testing." Health policy and technology vol. 10,2 (2021). doi: https://doi.org/10.1016/j.hlpt.2021.100511
Haas CB, Scrol A, Jujjavarapu C, Jarvik GP, Henrikson NB. Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testing. Health Policy Technol. 2021 Jun;10(2). doi: 10.1016/j.hlpt.2021.100511. Epub 2021 Apr 22. PMID: 34040952; PMCID: PMC8143032.
Copy Download .nbib Format: NLM
Real World Tracking of Modified Ride-On Car Usage in Young Children With Disabilities.

Journal of motor learning and development

Logan SW, Hospodar CM, Bogart KR, Catena MA, Feldner HA, Fitzgerald J, Schaffer S, Sloane B, Phelps B, Phelps J, Smart WD.
PMID: 33015208
J Mot Learn Dev. 2019 Dec;7(3):336-353. doi: 10.1123/jmld.2019-0015.

BACKGROUND: Go Baby Go is a community program that provides modified ride-on cars to young children with disabilities.AIMS: (1) To describe the real world modified ride-on car usage of young children with disabilities; (2) To compare subjectively reported modified...

Cite
Logan SW, Hospodar CM, Bogart KR, et al. Real World Tracking of Modified Ride-On Car Usage in Young Children With Disabilities. J Mot Learn Dev. 2019;7(3):336-353doi: 10.1123/jmld.2019-0015.
Logan, S. W., Hospodar, C. M., Bogart, K. R., Catena, M. A., Feldner, H. A., Fitzgerald, J., Schaffer, S., Sloane, B., Phelps, B., Phelps, J., & Smart, W. D. (2019). Real World Tracking of Modified Ride-On Car Usage in Young Children With Disabilities. Journal of motor learning and development, 7(3), 336-353. https://doi.org/10.1123/jmld.2019-0015
Logan, Samuel W, et al. "Real World Tracking of Modified Ride-On Car Usage in Young Children With Disabilities." Journal of motor learning and development vol. 7,3 (2019): 336-353. doi: https://doi.org/10.1123/jmld.2019-0015
Logan SW, Hospodar CM, Bogart KR, Catena MA, Feldner HA, Fitzgerald J, Schaffer S, Sloane B, Phelps B, Phelps J, Smart WD. Real World Tracking of Modified Ride-On Car Usage in Young Children With Disabilities. J Mot Learn Dev. 2019 Dec;7(3):336-353. doi: 10.1123/jmld.2019-0015. PMID: 33015208; PMCID: PMC7529107.
Copy Download .nbib Format: NLM
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN.
PMID: 32927050
Clin Gastroenterol Hepatol. 2022 Jan;20(1):183-193. doi: 10.1016/j.cgh.2020.09.015. Epub 2020 Sep 12.

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) surveillance rates are suboptimal in clinical practice. We aimed to elicit providers' opinions on the following aspects of HCC surveillance: preferred strategies, barriers and facilitators, and the impact of a patient's HCC risk...

Cite
Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, et al. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2020;20(1):183-193doi: 10.1016/j.cgh.2020.09.015.
Kim, N. J., Rozenberg-Ben-Dror, K., Jacob, D. A., Rich, N. E., Singal, A. G., Aby, E. S., Yang, J. D., Nguyen, V., Pillai, A., Fuchs, M., Moon, A. M., Shroff, H., Agarwal, P. D., Perumalswami, P., Chandna, S., Zhou, K., Patel, Y. A., Latt, N. L., Wong, R., Duarte-Rojo, A., Lindenmeyer, C. C., Frenette, C., Ge, J., Mehta, N., Yao, F., Benhammou, J. N., Bloom, P. P., Leise, M., Kim, H. S., Levy, C., Barnard, A., Khalili, M., & Ioannou, G. N. (2022). Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 20(1), 183-193. https://doi.org/10.1016/j.cgh.2020.09.015
Kim, Nicole J, et al. "Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 20,1 (2022): 183-193. doi: https://doi.org/10.1016/j.cgh.2020.09.015
Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2022 Jan;20(1):183-193. doi: 10.1016/j.cgh.2020.09.015. Epub 2020 Sep 12. PMID: 32927050; PMCID: PMC8657369.
Copy Download .nbib Format: NLM
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN.
PMID: 32927050
Clin Gastroenterol Hepatol. 2020 Sep 12; doi: 10.1016/j.cgh.2020.09.015. Epub 2020 Sep 12.

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) surveillance rates are suboptimal in clinical practice. We aimed to elicit providers' opinions on the following aspects of HCC surveillance: preferred strategies, barriers and facilitators, and the impact of a patient's HCC risk...

Cite
Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, et al. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2020;doi: 10.1016/j.cgh.2020.09.015.
Kim, N. J., Rozenberg-Ben-Dror, K., Jacob, D. A., Rich, N. E., Singal, A. G., Aby, E. S., Yang, J. D., Nguyen, V., Pillai, A., Fuchs, M., Moon, A. M., Shroff, H., Agarwal, P. D., Perumalswami, P., Chandna, S., Zhou, K., Patel, Y. A., Latt, N. L., Wong, R., Duarte-Rojo, A., Lindenmeyer, C. C., Frenette, C., Ge, J., Mehta, N., Yao, F., Benhammou, J. N., Bloom, P. P., Leise, M., Kim, H. S., Levy, C., Barnard, A., Khalili, M., & Ioannou, G. N. (2020). Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2020.09.015
Kim, Nicole J, et al. "Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2020). doi: https://doi.org/10.1016/j.cgh.2020.09.015
Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2020 Sep 12; doi: 10.1016/j.cgh.2020.09.015. Epub 2020 Sep 12. PMID: 32927050; PMCID: PMC8657369.
Copy Download .nbib Format: NLM
Clinical Use of Surface Electromyography to Track Acute Upper Extremity Muscle Recovery after Stroke: A Descriptive Case Study of a Single Patient.

Applied system innovation

Feldner HA, Papazian C, Peters KM, Creutzfeldt CJ, Steele KM.
PMID: 34778722
Appl Syst Innov. 2021 Jun;4(2). doi: 10.3390/asi4020032. Epub 2021 May 10.

Arm recovery varies greatly among stroke survivors. Wearable surface electromyography (sEMG) sensors have been used to track recovery in research; however, sEMG is rarely used within acute and subacute clinical settings. The purpose of this case study was to...

Cite
Feldner HA, Papazian C, Peters KM, et al. Clinical Use of Surface Electromyography to Track Acute Upper Extremity Muscle Recovery after Stroke: A Descriptive Case Study of a Single Patient. Appl Syst Innov. 2021;4(2)doi: 10.3390/asi4020032.
Feldner, H. A., Papazian, C., Peters, K. M., Creutzfeldt, C. J., & Steele, K. M. (2021). Clinical Use of Surface Electromyography to Track Acute Upper Extremity Muscle Recovery after Stroke: A Descriptive Case Study of a Single Patient. Applied system innovation, 4(2), . https://doi.org/10.3390/asi4020032
Feldner, Heather A, et al. "Clinical Use of Surface Electromyography to Track Acute Upper Extremity Muscle Recovery after Stroke: A Descriptive Case Study of a Single Patient." Applied system innovation vol. 4,2 (2021). doi: https://doi.org/10.3390/asi4020032
Feldner HA, Papazian C, Peters KM, Creutzfeldt CJ, Steele KM. Clinical Use of Surface Electromyography to Track Acute Upper Extremity Muscle Recovery after Stroke: A Descriptive Case Study of a Single Patient. Appl Syst Innov. 2021 Jun;4(2). doi: 10.3390/asi4020032. Epub 2021 May 10. PMID: 34778722; PMCID: PMC8589300.
Copy Download .nbib Format: NLM
Mortality in pediatric hydrocephalus.

Developmental medicine and child neurology

Tully HM, Doherty D, Wainwright M.
PMID: 34268734
Dev Med Child Neurol. 2022 Jan;64(1):112-117. doi: 10.1111/dmcn.14975. Epub 2021 Jul 15.

AIM: To clarify the extent to which medical comorbidities and goals-of-care decisions influence death among individuals with childhood-onset hydrocephalus.METHOD: This was a retrospective cohort study of 1705 individuals (759 males, 946 females, mean age 11y 5mo, SD 6y 6mo,...

Cite
Tully HM, Doherty D, Wainwright M. Mortality in pediatric hydrocephalus. Dev Med Child Neurol. 2021;64(1):112-117doi: 10.1111/dmcn.14975.
Tully, H. M., Doherty, D., & Wainwright, M. (2022). Mortality in pediatric hydrocephalus. Developmental medicine and child neurology, 64(1), 112-117. https://doi.org/10.1111/dmcn.14975
Tully, Hannah M, et al. "Mortality in pediatric hydrocephalus." Developmental medicine and child neurology vol. 64,1 (2022): 112-117. doi: https://doi.org/10.1111/dmcn.14975
Tully HM, Doherty D, Wainwright M. Mortality in pediatric hydrocephalus. Dev Med Child Neurol. 2022 Jan;64(1):112-117. doi: 10.1111/dmcn.14975. Epub 2021 Jul 15. PMID: 34268734; PMCID: PMC8671148.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 56 entries